Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Fang

Showing results (271-280 of 300) with videos related to

Pageof 30
Sort By:
European Journal of Haematology|June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 12, 2026
Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohortI-Wei Ho, Chung-Pin Li, Shih-Hung Yang, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
Therapeutic Advances in Medical Oncology|July 26, 2023
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity studyMing-Shen Dai, Ta-Chung Chao, Chang-Fang Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 27, 2013
Guideline-adherent therapy in patients with cardiovascular diseases in TaiwanJiann-Shing Jeng, Wei-Hsian Yin, Chin-Chou Huang, et al.
Liver Cancer|August 8, 2024
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394Shukui Qin, Weijia Fang, Zhenggang Ren, et al.
Plos One|March 11, 2015
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in TaiwanLi-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2014
Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan--a nationwide surveyWen-Yuan Lin, Tai-Yuan Chiu, Chih-Te Ho, et al.
International Journal of Hematology|June 14, 2014
Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statementBor-Sheng Ko, Cheng-Shyong Chang, Ming-Chih Chang, et al.
Pageof 30

Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
European Journal of Haematology|June 25, 2014
Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 12, 2026
Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohortI-Wei Ho, Chung-Pin Li, Shih-Hung Yang, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
Therapeutic Advances in Medical Oncology|July 26, 2023
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity studyMing-Shen Dai, Ta-Chung Chao, Chang-Fang Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 27, 2013
Guideline-adherent therapy in patients with cardiovascular diseases in TaiwanJiann-Shing Jeng, Wei-Hsian Yin, Chin-Chou Huang, et al.
Liver Cancer|August 8, 2024
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394Shukui Qin, Weijia Fang, Zhenggang Ren, et al.
Plos One|March 11, 2015
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in TaiwanLi-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2014
Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan--a nationwide surveyWen-Yuan Lin, Tai-Yuan Chiu, Chih-Te Ho, et al.
International Journal of Hematology|June 14, 2014
Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statementBor-Sheng Ko, Cheng-Shyong Chang, Ming-Chih Chang, et al.
Pageof 30